Thermo Fisher Scientific to Expand Kentucky Clinical Research Facility with $47.8 Million Investment
Introduction
Thermo Fisher Scientific Inc.'s PPD clinical research business is embarking on a significant expansion of its central laboratory operations in Kentucky.
Features
This project initiative includes the establishment of a new 65,000-square-foot facility in Covington, complementing its existing site in Highland Heights.
With a substantial investment of $47.8 million, this project aims to bolster Thermo Fisher's capacity to deliver essential services in central lab testing, biomarker operations, and sample management.
The project Support for Focus on supporting new therapies including vaccines and cell and gene therapies.
The expansion is poised to create more than 250 new jobs over the next eight years, contributing to economic growth and enhancing Thermo Fisher's capabilities in supporting pharmaceutical and biotech clients in bringing safe and effective medicines to patients.
The Project Renovation and construction anticipated to begin later this year, with phased implementation over the next several years.
This project underscores Thermo Fisher's commitment to expanding its global footprint in clinical research, reinforcing its capability to support pharmaceutical and biotech partners in advancing innovative therapies while contributing to economic vitality in Northern Kentucky.
Specification
Name Thermo Fisher Scientific
Type Expansion
